Abstract
We have carried out an audit of breast screening by mammography under 50 years of age in a cohort of 192 women attending family cancer clinics run by the South Thames genetic services. Of these women, six came from families in which a BRCA mutation had been identified, 61 had > 50%, 35 a 20–50% and 90 had < 20% chance of carrying a high risk mutation. In the 192 women in the screened cohort, 9 breast cancers were diagnosed (4.7%), all in high-risk women. Three were diagnosed at the prevalence screen. Three were detected mammographically at subsequent screening rounds; three were detected by breast self-examination (BSE) between screening episodes. One interval cancer was visible on mammogram at presentation but not at screening five months previously. A second cancer was also visible on mammogram at presentation but the normal screening mammogram had been 17 months earlier, outside the recommended interval. The remaining interval cancer was not visible on the mammogram. A total of 363 two-view screening mammograms were performed in the 280 person-years of follow-up; 109 additional investigations were generated: 23 recall mammograms, 18 symptomatic mammograms, 45 ultrasounds, 12 aspiration cytologies and 11 biopsies. Cytology diagnosed malignancy in 1 of 12 cases; breast biopsy in 9 of 11 cases. Twenty-three additional women had ultrasound screening only. This audit suggests that screening below the age 50 years may be unnecessary in families with a low chance of having a BRCA1 or -2 mutation, but it is important to screen high-risk women at least annually and possibly under 35 years.
Similar content being viewed by others
References 0
Hodgson S, Maher E. A practical guide to human cancer genetics. 2nd edition. Cambridge, UK: Cambridge University Press, 1999; 81–3. 0
Burke W, Daly M, Garber J et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer II. BRCA1 and BRCA2. JAMA 1997; 277: 997–1003. 0
Lalloo F, Boggis CRM, Evans GDR et al. Screening by mammography, women with a family history of breast cancer. Eur J Cancer 1998; 34: 878–83. 0
Kollias J, Sibbering DM, Blamey RW et al. Screening women aged less than 50 years with a family history of breast cancer. Eur J Cancer 1998; 34: 878–83. 0
Alexander FE, Anderson TJ, Brown HK et al. 14 years of follow up from the Edinburgh randomised trial of breast cancer screening. Lancet 1999; 353: 1903–8. 0
Eccles DM, Evans DG, Mackay J. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family study Group (UKCFSG). J Med Genet 2000; 37 (3): 203–9. 0
Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994; 73: 643–51. 0
Cohen M. First-degree relatives of breast-cancer patients: cognitive perceptions, coping, and adherence to breast self-examination. Behav Med 2002; 28 (1): 15–22 0
Thomas DB, Gao DL, Ray RM et al. Randomized trial of breast self examination in Shanghai: final results. J Natl Cancer Inst 2002; 94: 1420–1.
Lai M-S, Yen M-F, Kuo H-S et al. Efficacy of breast-cancer screening for female relatives of breast-cancer-index cases: Taiwan Multicentre Cancer Screening (TAMCAS). Int J Cancer 1998; 78: 21–6.
Gui GPH, Hogben RKF, Walsh G et al. The incidence of breast cancer from screening women according to predicted family history risk: does annual clinical examination add to mammography? Eur J Cancer 2001; 37: 1668–73.
Kuhl CK, Schmutzler RK, Leutner CC et al. Breast imaging in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000; 215(1): 267–79.
Verhoog LC, Brekelmans CTM, Seynaeve C et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998; 351: 316–21.
Robson M, Gilewski T, Haas B et al. BRCA-associated breast cancer in young women. J Clin Oncol 1998; 16: 1642–9.
Marcus JN, Watson P, Page DL et al. Hereditary breast cancer: Pathology, prognosis and BRCA1 and BRCA2 gene linkage. Cancer 1996; 77: 697–709.
Armes JE, Egan AJM, Southey MC et al. The histological phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations. A population-based study. Cancer 1998; 83(11): 2335–45, p. 2342.
Moller P, Reis MM, Evans G et al. Efficacy of early diagnosis and treatment in women with a family history of breast cancer. Dis Markers 1999; 15: 179–86.
Nixon RM, Pharoah P, Tabar L et al. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial. Rev Epidem Sante Publ 2000; 48: 325–31.
O'Driscoll D, Warren R, MacKay J et al. Screening with breast ultrasound in a population at moderate risk due to family history. J Med Screen. 2001; 8(2): 106–9.
Warner E, Plewes DB, Shumak RS et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001; 19(15): 3524–31.
Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997; 349: 1505-1510. Pg. 1508.
Brekelmans CTM, Seynaeve C, Bartels CCM et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene carriers and women with high familial risk. J Clin Oncol 2001; 19: 924–30.
Kerlikowske K, Grady D, Barclay J et al. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1996; 270: 2444–50.
Vasen HFA, Haites NE, Evans DGR et al. Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. Eur J Cancer 1998; 34(12): 1922–6.
Department of Health. Breast screening programme, England: 1997–1998, p. 7 (Table 3a). Retrieved from http://www.doh.gov. uk/public/bcscreen.htm in 1998.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murday, V., Pears, R., Ball, J. et al. An audit of screening for familial breast cancer before 50 years in the South Thames Region – have we got it right?. Familial Cancer 3, 29–34 (2004). https://doi.org/10.1023/B:FAME.0000026818.34049.84
Issue Date:
DOI: https://doi.org/10.1023/B:FAME.0000026818.34049.84